Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Patrizia Colucci"'
Autor:
Ilaria Piano, Arianna Votta, Patrizia Colucci, Francesca Corsi, Sara Vitolo, Chiara Cerri, Dario Puppi, Michele Lai, José Fernando Maya-Vetencourt, Massimiliano Leigheb, Chiara Gabellini, Elisabetta Ferraro
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-17 (2023)
Abstract Microglia chronic activation is a hallmark of several neurodegenerative diseases, including the retinal ones, possibly contributing to their etiopathogenesis. However, some microglia sub-populations have anti-inflammatory and neuroprotective
Externí odkaz:
https://doaj.org/article/d09e8042757b484b95e07469451601b6
Autor:
Alicia Gómez Sánchez, Ailis Moran, Patrizia Colucci, Basilio Colligris, Breandán N. Kennedy, Alexandro Moya López, Yolanda Álvarez
Publikováno v:
Open Research Europe, Vol 3 (2023)
Introduction Cigarette smoking adversely affects multiple aspects of human health including eye disorders such as age-related macular degeneration, cataracts and dry eye disease. However, there remains a knowledge gap in how constituents of cigarette
Externí odkaz:
https://doaj.org/article/7625cae7427d4646915a01e972016b79
Autor:
Patrizia Colucci, Martina Giannaccini, Matteo Baggiani, Breandán N. Kennedy, Luciana Dente, Vittoria Raffa, Chiara Gabellini
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1096 (2023)
Neuroprotective drug delivery to the posterior segment of the eye represents a major challenge to counteract vision loss. This work focuses on the development of a polymer-based nanocarrier, specifically designed for targeting the posterior eye. Poly
Externí odkaz:
https://doaj.org/article/9e283d5e21a04d8885aed0d715cd42b2
Autor:
Marta d'Amora, Patrizia Colucci, Alice Usai, Elena Landi, Lieselot Deleye, Luciana Dente, Francesco De Angelis, Vittoria Raffa, Francesco Tantussi
Publikováno v:
Precision Nanomedicine, Vol 3, Iss 4 (2020)
Several nanomedicine-based platforms, including polymeric micelles, dendrimers, and liposomes, have been developed and explored for targeted delivery of therapeutics in cancer. These nanoparticles are capable of delivering selectively antineoplastic
Externí odkaz:
https://doaj.org/article/9c351ed473354d27b6a3094124e919dd
Autor:
Marta d’Amora, Alice Usai, Vittoria Raffa, Luciana Dente, Francesco De Angelis, Francesco Tantussi, Elena Landi, Patrizia Colucci, Lieselot Deleye
Publikováno v:
Precision Nanomedicine (2020)
Several nanomedicine-based platforms, including polymeric micelles, dendrimers, and liposomes, have been developed and explored for targeted delivery of therapeutics in cancer. These nanoparticles are capable of delivering selectively antineoplastic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94a65e3a8774ee6ea67a2d6d7692cd73
http://prnano.scholasticahq.com/article/17629-heat-sensitive-poly-acrylamide-nanoparticle-for-cancer-treatment.pdf
http://prnano.scholasticahq.com/article/17629-heat-sensitive-poly-acrylamide-nanoparticle-for-cancer-treatment.pdf
Autor:
Gregorio Di Franco, Patrizia Colucci, Alfredo Falcone, Le Pollina, Vittoria Raffa, Enrico Vasile, Matteo Palmeri, Niccola Funel, Luca Morelli, Luciana Dente, Alice Usai
Publikováno v:
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 677 (2020)
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 677 (2020)
Animal &ldquo
avatars&rdquo
and co-clinical trials are being developed for possible use in personalized medicine in oncology. In a co-clinical trial, the cancer cells of the patient&rsquo
s tumor are xenotransplanted into the animal av
avatars&rdquo
and co-clinical trials are being developed for possible use in personalized medicine in oncology. In a co-clinical trial, the cancer cells of the patient&rsquo
s tumor are xenotransplanted into the animal av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d77d4ee6351c27dd3fdbca41dc15fc0
http://hdl.handle.net/11568/1037179
http://hdl.handle.net/11568/1037179
Autor:
Luciana Dente, Enrico Vasile, Alice Usai, Vittoria Raffa, Matteo Palmeri, Le Pollina, Patrizia Colucci, Alfredo Falcone, Niccola Funel, Gregorio Di Franco, Luca Morelli
Animal ‘‘Avatars’’ and co-clinical trials represent an emerging concept for implementing schemes of personalized medicine in oncology. In a co-clinical trial, the cancer cells of the patient tumor are xenotransplanted in the animal Avatar for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2414f0014e85e6b80ee878b9548704af
https://doi.org/10.1101/784041
https://doi.org/10.1101/784041
Publikováno v:
American Journal of Kidney Diseases. 40:161-168
Background: Results of peritoneal dialysis (PD) in cirrhotic patients with renal failure are debated. The aim of the present study is to assess the outcome of PD patients with liver cirrhosis. Methods: A retrospective study based on clinical records
Autor:
A. Pagano, Giovanna Lunghi, Francesco Locatelli, Claudio Ponticelli, Patrizia Colucci, Fabrizio Fabrizi, Silvia Finazzi
Publikováno v:
American Journal of Kidney Diseases. 38:1009-1015
Hepatitis C virus (HCV) infection is common in the dialysis population and patients with chronic renal failure (CRF) not requiring dialysis. HCV is the most important cause of chronic liver disease in dialysis patients; however, its role has been und
Autor:
F. Bamonti-Catena, Silvia Finazzi, Michela De Franceschi, Maria Antonietta Fasano, Cristina Novembrino, Patrizia Colucci, Amedeo F. De Vecchi, Cristina Patrosso
Publikováno v:
Nephron. 89:297-302
The possible role of folate supplementation in reducing hyperhomocysteinemia in dialysis patients has been reported in several recent papers. However, scant data are available for peritoneal dialysis patients; besides, none of these studies investiga